CIRCUTECH (08051) announced its interim results, with a profit attributable to shareholders of HKD 4.969 million, a year-on-year increase of 15.61%.
Xunzhihai (08051) announced its interim results for 2026, with total revenue of HK$229 million, a year-on-year increase of 4.77%; profit attributable to shareholders of HK$4.969 million, up 15.61% year-on-year; and earnings per share of HK$0.1908.
CIRCUTECH (08051) announced its interim results for 2026, reporting a revenue of HK$229 million, a year-on-year increase of 4.77%; profit attributable to shareholders of HK$4.969 million, a year-on-year increase of 15.61%; and earnings per share of HK$0.1908.
Related Articles
MODERN DENTAL (03600) has cancelled 636,000 repurchased shares.
ORIENTAL EXPL (00430) issues a profit warning, expecting that integrated profit attributable to shareholders for the first half of the year will decrease to approximately HK$3 million to HK$3.2 million.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.
MODERN DENTAL (03600) has cancelled 636,000 repurchased shares.
ORIENTAL EXPL (00430) issues a profit warning, expecting that integrated profit attributable to shareholders for the first half of the year will decrease to approximately HK$3 million to HK$3.2 million.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.
RECOMMEND
